Coronavirus News

Medindia's Press Release’ section provides the latest press release on Coronavirus from across the world for the global audience. This page links to 2367 Coronavirus press releases.

C2Sense and Princeton BioMeditech receive NIH RADx ® Tech Funding to Advance a Digitally Connected At-Home Diagnostic Reader for Sensitivity Enhancement of an OTC COVID-19/Flu A&B Rapid Test

The funds will be used to accelerate commercialization of a highly sensitive, fluorescent version of PBM's Status ™  COVID-19/Flu A&B antigen test used in conjunction with C2Sense's Halo ™ diagnostic reader. WATERTOWN, Mass. and ...


WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients

WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. InflaRx received emergency use authorization (EUA) from the FDA for Gohibic (vilobelimab) for the treatment of ...

COVID-19 Now Endemic WHO Reports; What Does it Mean for Testing? Kalorama Information Has Answers

The shift from pandemic to endemic doesn't alleviate all concerns as nations worldwide continue to manage COVID-19 along with other respiratory viruses and diseases. This includes maintaining and strengthening commitments to in vitro diagnostic ...

University of Missouri Laboratory for Infectious Disease Study Finds Technology Used in Widely Deployed Fingerprint Scanners Kills The Virus that Causes COVID-19

Study Reveals Electroluminescent Film-Based Fingerprint Scanners Are One of   the Safest Things to Touch in Public COLUMBIA, Mo. , May 9, 2023 /PRNewswire/ -- Researchers at the University of Missouri Laboratory for Infectious ...

International Covid Memorial Monument Design Competition Underway

CHICAGO, May 02, 2023 (GLOBE NEWSWIRE) -- An international design competition is underway for a Covid memorial monument. The winning design will be awarded $20,000 USD. A distinguished panel of judges will make the selection. The final ...

RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine

GERMANTOWN, Md. and GUANGZHOU, China , April 27, 2023 /PRNewswire/ --  RNAimmune, Inc. (the " Company " or " RNAimmune "), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, ...

ISA Pharmaceuticals to Present Pre-clinical Data on its Protective SLP Therapy Against SARS-CoV-2 at the CIMT Annual Meeting

OEGSTGEEST, The Netherlands , April 27, 2023 /PRNewswire/ -- ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that it will be ...

Doctors for Disaster Preparedness (DDP) Reviews New WHO Advice on COVID Vaccines

TUCSON, Ariz. , March 30, 2023 /PRNewswire/ -- Updated guidance on COVID vaccination by the World Health Organization (WHO) states that only high-risk groups should receive ongoing booster doses because they offer little impact in the ...

CGTN: How China keeps its promise to build a community of common health for mankind

BEIJING , March 25, 2023 /PRNewswire/ -- Recognizing China for its support during the pandemic, the Senate of the Dominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the ...

CGTN: How China continues optimizing its COVID-19 response amid other outbreaks

BEIJING , March 24, 2023 /PRNewswire/ -- China has entered a new phase of epidemic prevention and control after it downgraded the management of COVID-19 response into Class B infectious diseases. "The overall situation of epidemic response ...

Coronavirus News »

COVID-19 and Developmental Milestone Delays in Children

COVID-19 and Developmental Milestone Delays in Children

The COVID-19 pandemic disruptions and restrictions resulted in only "modest" delays in developmental milestones for infants and children aged 5 years and younger ( ). In a report published in JAMA Pediatrics, investigators evaluated ...

COVID-19 Vaccination's Efficacy in Adults With Mental Disorders

COVID-19 Vaccination's Efficacy in Adults With Mental Disorders

COVID-19 vaccines prove equally effective for adults with anxiety, depression , or mood disorders as for those without such diagnoses. This pioneering study marks a crucial step in...

Reflecting on Four Years Since India's First COVID-19 Lockdown

Reflecting on Four Years Since India's First COVID-19 Lockdown

Four years ago, on a balmy March evening, India implemented an unprecedented nationwide lockdown in response to early concerns about the Covid-19 pandemic ( ), imposing extensive restrictions on public movement...

New COVID Variant JN.1 Eludes Recent Vaccine Booster Efforts

New COVID Variant JN.1 Eludes Recent Vaccine Booster Efforts

The most recent series of Covid-19 vaccines provided no additional defense against the JN.1 variant, which remains in circulation. JN.1, from the lineage of Omicron , is an off-spin of BA.2.86.The variant, first detected in Luxembourg in ...

COVID-19's Impact on Life Expectancy Surpasses Prior Estimates

COVID-19's Impact on Life Expectancy Surpasses Prior Estimates

A recent study, featured in The Lancet, sheds light on previously unseen insights into the significantly high mortality rates caused by the COVID-19 pandemic worldwide. Countries like Mexico City, Peru, and Bolivia witnessed substantial ...

More Coronavirus News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.